New FDA Guidance on Penalties Relating to

By Carrie Mitchell and Jason Buck Recently, the FDA issued a guidance concerning the penalties for noncompliance with requirements. Sponsors conducting clinical trials should understand and follow the requirements for registering trials and reporting the results on The requirements have been in force since 2007 and were part of Section 801 of the … Continued

1 of 1
Back to top
Powered by GlobalLink OneLink Software